Skip to main content
. 2014 May 22;6(4):252–260. doi: 10.14740/jocmr1856w

Table 3. Dose Modifications of VCR in Patients Who Received Subsequent Chemotherapy at Our Hospital.

Factor Early-onset VIPN (-) (n = 24)
Early-onset VIPN (+) (n = 10)
P value
No. of patients (%) No. of patients (%)
VCR dose modifications at next cycle
  Unmodified 24 (100) 8 (80) 0.080
  Modified 0 (0) 2 (20)
    Discontinued 0 (0) 1 (10)
    Reduced 0 (0) 1 (10)